pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,664 catalysts · 6,366 phase readout · 2,292 8k filing · 388 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-17: 0 catalysts2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout6,366
  • 8k filing2,292
  • earnings388
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT07087184: Gauging Outcomes of Total Milk Ingestion on Lipid and gControl

Sponsor: University of California, San Francisco. Phase: NA. Conditions: Heart Diseases, Cardiovascular Disease

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05416333: Azelaic Acid as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA)

Sponsor: Wake Forest University Health Sciences. Phase: EARLY_PHASE1. Conditions: Central Centrifugal Cicatricial Alopecia

full page →ctgov ↗
›RECRUITINGphase readoutNCT06865638: Efficacy and Safety of Colorectal Anastomotic Leak Testing

Sponsor: Nanchong Central Hospital. Phase: NA. Conditions: Colorectal Cancer, Leakage Testing, Colorectal Surgery, Complications, Anastomotic Leakage

full page →ctgov ↗
›RECRUITINGphase readoutNCT06835738: Implementation of Multiple Micronutrient Supplementation (MMS) for Pregnant Women in Uganda

Sponsor: Johns Hopkins Bloomberg School of Public Health. Phase: NA. Conditions: Nutrient Deficiency

full page →ctgov ↗
›RECRUITINGphase readoutNCT07284758: A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

Sponsor: C4 Therapeutics, Inc.. Phase: PHASE2. Conditions: Multiple Myeloma, Relapsed/Refractory Multiple Myeloma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07374848: Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors

Sponsor: Zai Lab (Shanghai) Co., Ltd.. Phase: PHASE1. Conditions: Solid Tumors, Sarcomas

full page →ctgov ↗
›RECRUITINGphase readoutNCT07668648: Interscalene Brachial Plexus Block Versus Serratus Posterior Superior Intercostal Plane Block for Arthroscopic Shoulder Surgery

Sponsor: Ferit Yetik. Phase: NA. Conditions: Postoperative Pain, Shoulder Arthroscopy

full page →ctgov ↗
›RECRUITINGphase readoutNCT06958848: 16F vs 24F Chest Drain After Minimally Invasive Lobectomy and/or Segmentectomy

Sponsor: University Hospital, Basel, Switzerland. Phase: NA. Conditions: Pneumothorax, Pleural Effusion

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05101148: Phase I Study to Assess the Effect of Food on the PK and Gastrointestinal Tolerability of Selumetinib in Adolescent Children With Neurofibromatosis Type 1 Related Plexiform Neurofibromas

Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Neurofibromatosis Type 1

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT01575548: Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery

Sponsor: National Cancer Institute (NCI). Phase: PHASE3. Conditions: Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v7

full page →ctgov ↗
›RECRUITINGphase readoutNCT07406048: Real-World Effectiveness of a Triple Combination BDP/FF/GB Extrafine in a Single Pressurised Metered Dose Inhaler in Brazilian COPD Patients

Sponsor: Chiesi Farmaceutica Ltda.. Phase: . Conditions: COPD (Chronic Obstructive Pulmonary Disease)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06761326: Right Versus Left Distal Axillary Vein Cannulation

Sponsor: Alexandria University. Phase: NA. Conditions: Infraclavicular Vein Cannulation, Venous Cannulation

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04208178: Study of Alpelisib (BYL719) in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy in Patients With HER2-positive Advanced Breast Cancer With a PIK3CA Mutation

Sponsor: Novartis Pharmaceuticals. Phase: PHASE3. Conditions: Advanced HER2+Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07714785: Impact of EEG-guided Sevofluorane on Opioid Consumption and Quality of Awakening

Sponsor: Pontificia Universidad Catolica de Chile. Phase: NA. Conditions: Pediatric Anesthesia, Emergence Delirium, Anesthesia, Postoperative Pain, Tonsillectomy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07645885: Fermented Foods and Bone Health: Investigating the Gut-Bone Axis in Premenopausal Vegan Women

Sponsor: Isabelle Herter-Aeberli. Phase: NA. Conditions: Bone, Bone Health

full page →ctgov ↗
›RECRUITINGphase readoutNCT07482943: The Effect of Dapagliflozin on Exercise and Cardiac Functional Status of Patients After Fontan Procedure

Sponsor: The University of Hong Kong. Phase: PHASE4. Conditions: Fontan, Heart Failure, Dapagliflozin, Cardiovascular Diseases, Sodium-GLucose coTransporter-2 Inhibitors

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06604715: A Study of JNJ-87562761 in Participants With Relapsed or Refractory Multiple Myeloma

Sponsor: Janssen Research & Development, LLC. Phase: PHASE1. Conditions: Relapsed or Refractory Multiple Myeloma

full page →ctgov ↗
›COMPLETEDphase readoutNCT04670835: Modeling the Impact of Inbound Call Distribution Virtualization in Emergency Medical Communication Centers (EMCCs) on Their Service Level

Sponsor: Nantes University Hospital. Phase: . Conditions: Emergency Medical Service Communication Systems, Health Care

full page →ctgov ↗
›COMPLETEDphase readoutNCT07083908: A Comparison of THD® Anopress With High Resolution Anorectal Manometry

Sponsor: King's College Hospital NHS Trust. Phase: NA. Conditions: Obstetric Anal Sphincter Injury

full page →ctgov ↗
›RECRUITINGphase readoutNCT07357285: Safety and Efficacy Evaluation of the iNstroke 4F Thromboaspiration Catheter in Patients With Acute Ischaemic Stroke Due to Primary Distal Medium Vessel Occlusions (DMVO)

Sponsor: iVascular S.L.U.. Phase: NA. Conditions: Acute Ischemic Stroke

full page →ctgov ↗
›RECRUITINGphase readoutNCT07638943: Refitting Satisfied INFUSE One-Day Multifocal Wearers to DAILIES TOTAL1 Multifocal Contact Lenses

Sponsor: Gordon Schanzlin New Vision. Phase: NA. Conditions: Contact Lens Comfort and Successful Refitting, Presbyopia

full page →ctgov ↗
›RECRUITINGphase readoutNCT04999215: Choline-PET: Exploratory Study Assessing the Potential Role of F-choline PET Imaging in New and Emerging Indications

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM). Phase: PHASE3. Conditions: Lesion With Known or Suspected F-choline Uptake

full page →ctgov ↗
›RECRUITINGphase readoutNCT07239908: Resuscitation Enhancement to Avoid Rearrest Through Evidence-based Strategies in Prehospital Post-resuscitation Care

Sponsor: Siriraj Hospital. Phase: PHASE2. Conditions: Out-of-hospital Cardiac Arrest (OHCA)

full page →ctgov ↗
›RECRUITINGphase readoutNCT05583708: Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer

Sponsor: Weill Medical College of Cornell University. Phase: PHASE2. Conditions: Merkel Cell Carcinoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07756008: Bladder-Sparing Treatment With Disitamab Vedotin and Toripalimab With or Without Pelvic Lymph Node Dissection in Bladder Cancer

Sponsor: Tianjin Medical University Second Hospital. Phase: PHASE2. Conditions: Bladder Urothelial Carcinoma, Muscle-invasive Bladder Cancer, Bladder Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT05810025: FHIR-Enhanced RealRisks to Improve Accuracy of Breast Cancer Risk Assessments

Sponsor: Columbia University. Phase: NA. Conditions: Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07429617: Effects of Darkness Retreat: a Pilot Study

Sponsor: University of Social Sciences and Humanities, Warsaw. Phase: NA. Conditions: Study Protocol Feasibility, Non Clinical Anxiety, Non Clinical Worry, Non Clinical Rumination

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07593768: Clinical and Prognostic Significance of Periodontitis in Patients With Arterial Hypertension

Sponsor: I.M. Sechenov First Moscow State Medical University. Phase: . Conditions: Arterial Hypertension, Periodontitis

full page →ctgov ↗
›COMPLETEDphase readoutNCT07546968: CiNPWT Using in Mastectomy Wound Care After DIEP Flaps for Breast Reconstruction

Sponsor: Chiayi Christian Hospital. Phase: . Conditions: Mastectomy, Breast Reconstruction, Closed-Incision Negative Pressure Therapy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07697768: Photobiomodulation for Vaginal Dysfunctions: Home-Based vs Outpatient Treatment

Sponsor: Patricia Lordelo. Phase: NA. Conditions: Genitourinary Syndrome of Menopause (GSM), Bacterial Vaginosis, Vulvovaginal Candidiasis (VVC)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03038568: Assessing How Normal Variations in CT Scanning Affects Its Interpretation

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: . Conditions: Colorectal Cancer Metastatic

full page →ctgov ↗
›COMPLETEDphase readoutNCT04117074: Thoracic Epidural Analgesia vs Surgical Site Infiltration With Liposomal Bupivacaine Following Open Gynecologic Surgery

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Phase: PHASE3. Conditions: Surgery, Analgesia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07685418: Ischemic Compression and Home Exercise in Non-Specific Neck Pain

Sponsor: Istanbul Rumeli University. Phase: NA. Conditions: Myofascial Trigger Points, Musculoskeletal Pain, Non-specific Neck Pain, Neck Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT05366218: Tafasitamab (MOR00208) in Pediatric Patients With Relapsed or Refractory Acute B Lineage Leukemia

Sponsor: University Hospital Tuebingen. Phase: PHASE1. Conditions: ALL, Childhood B-Cell, Acute Lymphoid Leukemia Relapse, Acute Lymphocytic Leukemia Refractory

full page →ctgov ↗
›COMPLETEDphase readoutNCT06095518: DIC Markers and Thrombin Generation Parameters in Patients on ECMO Support: a Pilot Study

Sponsor: Queen Mary Hospital, Hong Kong. Phase: . Conditions: Extracorporeal Circulation; Complications, Extracorporeal Membrane Oxygenation Complication

full page →ctgov ↗
›COMPLETEDphase readoutNCT07604818: Comparison of Sucking in Premature Infants and Infants With Pierre Robin Sequence

Sponsor: Hospices Civils de Lyon. Phase: . Conditions: Premature Infants, Pierre Robin Sequence, Feeding Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT07763990: THE EVALUATION OF THE SAFETY AND PERFORMANCE OF AN INJECTABLE HYALURONIC ACID FILLER

Sponsor: Hallura Ltd.. Phase: NA. Conditions: Lips Enhancement Nasolabial Fold Correction Midface Volume Deficit

full page →ctgov ↗
›RECRUITINGphase readoutNCT07725497: A Study of Luspatercept in People With Anemia

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Anemia, Chronic Kidney Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT07539597: Innovative Approaches to Hypertension Management in High-Risk Emergency Department Populations

Sponsor: Icahn School of Medicine at Mount Sinai. Phase: NA. Conditions: Asymptomatic Hypertension

full page →ctgov ↗
›RECRUITINGphase readoutNCT07225010: Tele-PCIT for Healthy Relationships in Families At-Risk

Sponsor: Medical University of South Carolina. Phase: NA. Conditions: Disruptive Behavior, Pediatrics

full page →ctgov ↗
›COMPLETEDphase readoutNCT03284710: Safety and Immunogenicity of Clade C ALVAC and gp120 HIV Vaccine

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: PHASE1. Conditions: HIV Infections

full page →ctgov ↗
›RECRUITINGphase readoutNCT06857760: Effects of Three Different Methods Applied to Patients After Spine Surgery on Nausea, Thirst and Comfort

Sponsor: Ondokuz Mayıs University. Phase: NA. Conditions: Spinal Surgery

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07371013: Fecal Microbiota Transplantation in Children With Autism Spectrum Disorder and Gastrointestinal Symptoms

Sponsor: Institute of Mother and Child, Warsaw, Poland. Phase: NA. Conditions: Autism Spectrum Disorder, Gastrointestinal Symptoms

full page →ctgov ↗
›COMPLETEDphase readoutNCT07376213: Effects of a Home-Based Exercise Program During Radiotherapy

Sponsor: Burak Ertürk. Phase: NA. Conditions: Head and Neck Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02194660: Fragility Fracture Liaison Service Project

Sponsor: National Taiwan University Hospital. Phase: . Conditions: Osteoporosis, Fracture

full page →ctgov ↗
›COMPLETEDphase readoutNCT03414060: Feasibility of the Menstrual Cup for VVF

Sponsor: University of Ghana Medical School. Phase: NA. Conditions: Vaginal Fistula, Vesico Vaginal Fistula, Obstetric; Injury

full page →ctgov ↗
›COMPLETEDphase readoutNCT07531160: Baseline Predictors of Response to Radial Pressure Wave Therapy in Knee Osteoarthritis

Sponsor: Hospital Civil de Guadalajara. Phase: . Conditions: Osteoarthritis, Knee, Knee Osteoarthritis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06335160: Possible Efficacy and Safety of Mebendazole in Patients With Ulcerative Colitis Treated With Mesalamine

Sponsor: Tanta University. Phase: NA. Conditions: Ulcerative Colitis

full page →ctgov ↗
›COMPLETEDphase readoutNCT04737720: Intravenous ACP-501 for Familial LCAT Deficiency (rhLCAT)

Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: . Conditions: Familial LCAT Deficiency

full page →ctgov ↗
›RECRUITINGphase readoutNCT05127824: Autologous Dendritic Cell Vaccine in Kidney Cancer

Sponsor: Jodi Maranchie. Phase: PHASE2. Conditions: Carcinoma, Renal Cell

full page →ctgov ↗
← prev
page 172 of 174
next →